Literature DB >> 23763373

Thrombospondin-2 facilitates assembly of a type-I collagen-rich matrix in marrow stromal cells undergoing osteoblastic differentiation.

Andrea I Alford1, Andrew Z Golicz, Amber Lee Cathey, Anita B Reddy.   

Abstract

We examined the effects of Thrombospondin-2 (TSP2) deficiency on assembly of collagenous extracellular matrix (ECM) by primary marrow-derived mesenchymal stromal cells (MSC) undergoing osteoblast differentiation in culture. After 30 d, wild-type cells had accumulated and mineralized a collagen-rich insoluble matrix, whereas the TSP2-null cultures contained markedly lower amounts of matrix collagen and displayed reduced mineral. Differences in matrix collagen were seen as early as day 9, at which time wild-type cultures contained more total collagen per cell than did TSP2-null cells. Collagen was unevenly distributed amongst different extracellular compartments in the two cell-types. Collagen levels in conditioned medium of wild-type cells were higher than those of TSP2-null cells, but were roughly equivalent in the acid-soluble, newly cross-linked matrixes. Conversely, the mature, cross-linked acid-insoluble matrix layer of wild-type cells contained about twice as much collagen as TSP2-null cell-derived matrix. Western blot analysis of type-I collagen in detergent-soluble and insoluble matrix fractions supported the premise that matrix collagen levels were reduced in TSP2-null MSC undergoing osteoblastic differentiation in vitro. Western blot and immunofluorescent analysis suggested that assembly of fibronectin into matrix was not affected by TSP2 deficiency. Instead, western blots of conditioned medium demonstrated a marked reduction in mature, fully processed type-I collagen in the absence of TSP2. Our data suggest that in the context of osteoblast differentiation, TSP2 promotes the assembly of a type-I collagen-rich matrix by facilitating pro-collagen processing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23763373      PMCID: PMC4091640          DOI: 10.3109/03008207.2013.811236

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  29 in total

1.  Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.

Authors:  Z Yang; T R Kyriakides; P Bornstein
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1.

Authors:  Teet Velling; Juha Risteli; Krister Wennerberg; Deane F Mosher; Staffan Johansson
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

3.  Genetic evidence for key roles of decorin and biglycan in dentin mineralization.

Authors:  Naoto Haruyama; Taduru L Sreenath; Shigeki Suzuki; Xiaomei Yao; Zhigang Wang; Yong Wang; Cherlita Honeycutt; Renato V Iozzo; Marian F Young; Ashok B Kulkarni
Journal:  Matrix Biol       Date:  2009-02-12       Impact factor: 11.583

4.  Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3.

Authors:  Alain Colige; Isabel Vandenberghe; Marc Thiry; Charles A Lambert; Jozef Van Beeumen; Shi-Wu Li; Darwin J Prockop; Charles M Lapiere; Betty V Nusgens
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

5.  Assembly of collagen fibrils de novo by cleavage of the type I pC-collagen with procollagen C-proteinase. Assay of critical concentration demonstrates that collagen self-assembly is a classical example of an entropy-driven process.

Authors:  K E Kadler; Y Hojima; D J Prockop
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

6.  MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1.

Authors:  G Xiao; D Jiang; P Thomas; M D Benson; K Guan; G Karsenty; R T Franceschi
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 7.  Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis.

Authors:  P Bornstein; T R Kyriakides; Z Yang; L C Armstrong; D E Birk
Journal:  J Investig Dermatol Symp Proc       Date:  2000-12

8.  Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2.

Authors:  Z Yang; D K Strickland; P Bornstein
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

9.  The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation.

Authors:  Kurt D Hankenson; Paul Bornstein
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

10.  Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.

Authors:  A Corsi; T Xu; X D Chen; A Boyde; J Liang; M Mankani; B Sommer; R V Iozzo; I Eichstetter; P Gehron Robey; P Bianco; M F Young
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

View more
  11 in total

1.  Thrombospondin-2 deficiency in growing mice alters bone collagen ultrastructure and leads to a brittle bone phenotype.

Authors:  Eugene Manley; Joseph E Perosky; Basma M Khoury; Anita B Reddy; Kenneth M Kozloff; Andrea I Alford
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

Review 2.  Thrombospondin-2 and extracellular matrix assembly.

Authors:  Nicole E Calabro; Nina J Kristofik; Themis R Kyriakides
Journal:  Biochim Biophys Acta       Date:  2014-01-15

3.  Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model.

Authors:  Longze Zhang; Tao Wang; Martin Chang; Claire Kaiser; Jason D Kim; Tianyu Wu; Xiaoyi Cao; Xinping Zhang; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2017-07-19       Impact factor: 6.741

4.  Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29.

Authors:  N E Calabro; A Barrett; A Chamorro-Jorganes; S Tam; N J Kristofik; Hao Xing; Ayomiposi M Loye; W C Sessa; K Hansen; T R Kyriakides
Journal:  Matrix Biol       Date:  2019-03-13       Impact factor: 11.583

5.  Substance P increases CCN2 dependent on TGF-beta yet Collagen Type I via TGF-beta1 dependent and independent pathways in tenocytes.

Authors:  Nagat Frara; Paul W Fisher; Yingjie Zhao; Joseph T Tarr; Mamta Amin; Steven N Popoff; Mary F Barbe
Journal:  Connect Tissue Res       Date:  2017-04-12       Impact factor: 3.417

6.  Compound deletion of thrombospondin-1 and -2 results in a skeletal phenotype not predicted by the single gene knockouts.

Authors:  Andrea I Alford; Chris Stephan; Kenneth M Kozloff; Kurt D Hankenson
Journal:  Bone       Date:  2021-08-20       Impact factor: 4.398

7.  Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix.

Authors:  Dae Joong Kim; Elena D Christofidou; Douglas R Keene; Marwah Hassan Milde; Josephine C Adams
Journal:  Mol Biol Cell       Date:  2015-05-20       Impact factor: 4.138

8.  Modulation of the extracellular matrix patterning of thrombospondins by actin dynamics and thrombospondin oligomer state.

Authors:  Andrew L Hellewell; Xianyun Gong; Karsten Schärich; Elena D Christofidou; Josephine C Adams
Journal:  Biosci Rep       Date:  2015-05-20       Impact factor: 3.840

Review 9.  The Bone Extracellular Matrix in Bone Formation and Regeneration.

Authors:  Xiao Lin; Suryaji Patil; Yong-Guang Gao; Airong Qian
Journal:  Front Pharmacol       Date:  2020-05-26       Impact factor: 5.810

Review 10.  The Regulation of Collagen Processing by miRNAs in Disease and Possible Implications for Bone Turnover.

Authors:  Tomasz P Lehmann; Urszula Guderska; Klaudia Kałek; Maria Marzec; Agnieszka Urbanek; Alicja Czernikiewicz; Maria Sąsiadek; Paweł Karpiński; Andrzej Pławski; Maciej Głowacki; Paweł P Jagodziński
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.